EQT X fund has entered into an agreement to acquire Zeus Company Inc from the Tourville family. Zeus is known for designing and developing fluoropolymer tubing for medical devices and has delivered innovative components for complex catheters for over 50 years. The company serves over 300 customers globally, and EQT plans to invest in additional capacity, R&D, and operational excellence to support the company’s growth in the medical fields. John Groetelaars, former CEO of Hillrom, will serve as Zeus’ Executive Chairman upon completion of the transaction. The transaction is expected to close in Q1 2024, subject to regulatory approvals and customary closing conditions.
Source link
EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures
